Myraquat
Industrielaan 12
9800 Deinze
BE
Myraquat
Foundation date
14/04/2020
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
Myraquat develops therapeutic compounds acting as membrane modulators to control pathogenic microorganisms.
Upcoming events
All events-
2211 '21
Translational Immunology
Event by: VIB -
2710 '21
New Horizons in Alzheimer's Disease
Event by: VIB -
1611 '21
DxPx Conference 2021
Event by: DxPx Conference
Latest news
More news-
reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase
Thursday October 21st 2021
Read more
-
Mithra announces Estelle® launch in Belgium
Thursday October 21st 2021
Read more
-
Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes
Wednesday October 20th 2021
Read more